Search PubMed⌕ Search

Biomedical subjects

D D Do

Publications and source records attributed to D D Do.

At least 55 records · Page 3Linked to original sources
PubMed2000

Percutaneous catheter thrombus aspiration for acute or subacute arterial occlusion of the legs: how much thrombolysis is needed?

OBJECTIVE: To evaluate the role of a combined percutaneous endovascular approach including thrombus aspiration, catheter thrombolysis, and percutaneous transluminal angioplasty (PTA) to treat acute and subacute occlusions of native leg arteries. MATERIALS AND METHODS: Retrospective evaluation of the effectiveness and safety of this catheter therapy in 89 consecutive patients (93 legs) in a single centre. RESULTS: Treatment was initially successful in 90% of legs. Mortality at 30 days was 8%, and at 12 months 19%. Amputation-free survival at 12 months was 78%. Aspiration alone was sufficient in 31% of cases, urokinase (mean dose 112 500+/-55 900 IU) was used in 22%, PTA was added in 69%. There was no major bleeding except for one false aneurysm treated by ultrasound-guided compression. Secondary interventions within 12 months were required in 30% of cases (14 endovascular, 16 open surgical procedures). CONCLUSIONS: Catheter thrombus aspiration in combination with thrombolysis and/or PTA is highly effective. Only in a minority of patients are thrombolytics in modest doses necessary, and serious bleeding complications are rare. We recommend this procedure as first-line treatment for acute or subacute infrainguinal arterial occlusions.

Acute Disease↗
PubMed2000

Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: a prospective follow-up study.

PURPOSE: To compare the results of balloon percutaneous transluminal renal angioplasty (PTRA) and stent placement in atherosclerotic ostial, proximal, and isolated truncal stenoses. MATERIALS AND METHODS: Between January 1994 and April 1998 the authors prospectively followed up 163 consecutive patients with 200 atherosclerotic renal arterial lesions after primary PTRA or primary stent placement. Duplex ultrasonography was performed 1 day and 3, 6, and 12 months later. RESULTS: The primary 12-month PTRA patency rates were 34% (21 of 33 atherosclerotic lesions) for ostial stenoses, 65% (20 of 60) for proximal stenoses, and 83% (five of 30) for truncal stenoses (chi(2) value, 15.63; P <.001). The corresponding stent patency rates were 80% (four of 21), 72% (nine of 34), and 66% (five of nine), respectively (chi(2) value, 4.11; not significant). Significant stent-related reduction in risk of restenosis was limited to the ostial stenoses (P =.002). CONCLUSION: Renal arterial stent placement considerably improves patency in ostial stenoses, but compared with the technically successful PTRA, it does not significantly improve primary patency in proximal and isolated truncal renal arterial stenoses.

Adult↗
PubMed1999

Stenting of the peripheral, renal and supraaortic arteries and the aorta.

In spite of the limited experience with the newer types of stents (covered stents, stent grafts) and the resultant reservations, this development is one of the most fascinating features of the last decade and opens new perspectives for vascular medicine and endovascular surgery in the near future. At present stents in the aortoiliac region, including the origin of renal arteries, appear to fulfil their promise. In the femoropopliteal and crural region there are still unresolved problems (relapse rate around 50%), and stents should be implanted only in salvage situations. However, primary application of stents cannot be recommended even in the unproblematic regions, due to the possibility of stent-induced intimal hyperplasia and the high cost of the devices. In other more controversial regions such as the carotid arteries, the application is still experimental and should be performed under controlled study circumstances.

Aged↗
PubMed1999

A prospective, randomized evaluation of nonsurgical closure of femoral pseudoaneurysm by compression device with or without ultrasound guidance.

Femoral artery pseudoaneurysm (PA) is a significant complication following diagnostic or therapeutic catheterization. The treatment of choice for femoral artery PA is freehand ultrasound-guided compression repair (UGCR). An alternative method is compression by mechanical devices. The study evaluated the mechanical compression device (FemoStop) with (G1) or without (G2) ultrasound guidance for initial placement in a randomized fashion. Thirty-eight patients (20 women, 18 men) age 40 to 85 (mean 54) years with clinical signs of PA underwent diagnostic color Doppler ultrasound. Randomization yielded 19 patients each for G1 and G2. PA occurred after 12 diagnostic cardiac catheterizations, 18 coronary stent implantations or balloon angioplasties, 2 electrophysiology procedures, and 6 peripheral percutaneous transluminal angioplasties. The G1 protocol was successful in 15 of 19 patients (79%), with a mean compression time of 28 min. The three other patients were treated successfully with UGCR. Only one patient needed vascular surgery. The G2 protocol was successful in 14 of 19 patients (74%) with a mean compression time of 33 min. The failed patients were treated successfully: three with UGCR and two with the same mechanical compression device now positioned under ultrasound control. Compression therapy with the compression device (FemoStop) for iatrogenic femoral pseudoaneurysm does not require ultrasound guidance for positioning. Cathet. Cardiovasc. Intervent. 47:304-309, 1999.

Aged↗
PubMed1999

The site of atheromatosis in the subclavian and vertebral arteries and its implication for angioplasty.

We analysed the site of plaques and stenoses in the subclavian and vertebral arteries, to improve the safety of percutaneous transluminal angioplasty (PTA) in high-risk patients. These lesions were assessed on arteriograms of 35 patients with stenoses and occlusions of the subclavian and vertebral arteries; the degree of stenoses was measured. Of 19 subclavian artery stenoses 17 (89%) were in the segment proximal to the vertebral artery; 30 (79%) of 38 vertebral artery stenoses were on the medial wall. With this knowledge, a double-balloon technique using a simultaneous transbrachial and transfemoral approach for angioplasty of high-risk subclavian or combined subclavian and vertebral artery stenoses and occlusions was used successfully in seven patients. This new technique may broaden the endovascular therapeutic possibilities in the rare but dangerous situation where plaque extends directly from the stenotic subclavian artery into the origin of the vertebral artery.

Aged↗
PubMed1999

Mural aortic thrombi: An important cause of peripheral embolization.

PURPOSE: Arterial thromboembolism in patients with an unknown source of embolization is still associated with significant morbidity and mortality. The advent of transesophageal echocardiography (TEE) and magnetic resonance imaging (MRI) and the more frequent use of computed tomography (CT) have led to the identification of mural aortic thrombi (MAT) as a source of distal embolization in a much higher proportion of patients than previously appreciated. The incidence, diagnosis, and treatment of patients with MAT is reported. METHODS: In a prospective study, from January 1996 to December 1998, 89 patients with acute embolic events underwent an extensive diagnostic workup, consisting of TEE, CT, or MRI, to detect the source of embolization. Patients in whom the heart (n = 51), occlusive aortoiliac disease (n = 16), or aortic aneurysms (n = 12) was identified as the source of embolization were excluded. RESULTS: Five female and three male patients, with a median age of 63 years (range, 35 to 76 years), with bilateral or repetitive embolic events resulting from MAT were identified, representing 9% of all patients with arterial thrombembolism. All patients had several risk factors for atherosclerosis, but only one young patient had a single risk factor that promoted thrombosis. Successful percutaneous catheter aspiration embolectomy was performed in six patients. The remaining two patients underwent surgical thromboembolectomy. A below-knee amputation had to be performed in two patients, thus representing a morbidity of the primary treatment of 25%. MAT of equal value were detected in the ascending (n = 1) and thoracic aorta (n = 3) by means of TEE, CT, or MRI. MAT in the abdominal aorta (n = 4) were identified by means of CT and MRI. Surgical removal of MAT was performed in seven patients by means of graft replacement of the ascending aorta (n = 1), open thrombectomy of the descending aorta (n = 2), and thrombendarterectomy of the abdominal aorta (n = 4), without intraoperative or postoperative complications. No recurrence of MAT occurred during a median follow-up period of 13 months (range, 4 to 24 months). CONCLUSION: MAT represent an important source of arterial thrombembolism. A diagnostic workup of the aorta, preferably by means of CT or MRI, should be performed in all patients in whom other sources of embolization have been ruled out. The ideal therapeutic approach to these patients still awaits prospective evaluation. However, based on our experience, MAT can be successfully treated with a definitive surgical procedure in selected patients, with low mortality and morbidity.

Adult↗
PubMed1999

PTA of the subclavian and innominate arteries: long-term results.

BACKGROUND: To investigate the long-term clinical and duplex sonographic results of percutaneous transluminal angioplasty (PTA) of the subclavian and innominate arteries, and the potential of a new double balloon technique to avoid cerebrovascular thromboembolism. PATIENTS AND METHODS: Forty-three PTAs were performed on 38 subclavian, four innominate arteries and one subclavian-subclavian bypass in 37 patients. In three instances a protective double balloon technique was used. Indication for the intervention was: subclavian steal syndrome (n = 14 [38%]), upper extremity arterial insufficiency (n = 26 [70%]), peripheral thromboembolism (n = 8 [22%]) and PRIND/stroke (n = 3 [8%]). Analysis of long-term follow-up (median 15, range 2 to 100 months) was possible of 28 patients including duplex sonographic assessment in 23 patients. The cumulative patency rate was calculated by means of life-table analysis. RESULTS: Technical success was achieved in 36 endovascular procedures (84%). Minor peripheral catheter complications occurred in three interventions (7%), cerebrovascular thromboembolism in four (9%). No cerebrovascular complications were seen using the double balloon technique. On final check-up 4 patients (14%) suffered from subclavian steal syndrome, 3 (11%) from mild upper extremity arterial insufficiency and one (4%) from rest pain. Duplex sonography showed no stenosis in 12 of 23 patients (52%) and a stenosis of less than 50% in 8 (35%). The life-table analysis showed a secondary cumulative patency rate of 72% after 100 months with all restenoses occurring within 24 months. CONCLUSIONS: PTA of the subclavian and innominate arteries appears to be a useful alternative to surgery with a low complication rate. The long-term patency rate of 72% is comparable to results of other series. In high risk situations cerebrovascular complications may be reduced using the new double balloon technique.

Adult↗
PubMed1998

Pseudoaneurysm of femoral artery after catheterisation: treatment by a mechanical compression device guided by colour Doppler ultrasound.

BACKGROUND: Femoral artery pseudoaneurysm is a significant complication in patients undergoing diagnostic or therapeutic catheterisation. First choice treatment for pseudoaneurysm is freehand ultrasound guided compression repair, which is time consuming and uncomfortable for the patient and operator. AIM: To explore a mechanical compression device (FemoStop) as an alternative treatment for iatrogenic femoral artery pseudoaneurysm. METHODS: Fourteen patients with pseudoaneurysm were considered for treatment with FemoStop after a brief freehand ultrasound guided compression repair to confirm the compressibility of the lesion. The FemoStop compression was applied for 20 minutes. The result was controlled with colour Doppler ultrasound, and a second cycle of 20 minutes followed if necessary. RESULTS: FemoStop compression was successful in 13 of the 14 patients. The mean compression time was 33 minutes (range, 20-60). The mean number of compression periods was 1.6 (range 1-3). FemoStop compression was successful in all 11 patients not taking anticoagulants and in two of three patients receiving anticoagulants. The mean compression time in patients given oral or intravenous anticoagulants was longer (50 v 27 minutes). Colour Doppler ultrasound 12 hours after the procedure indicated no recurrence of pseudoaneurysm in the 13 patients with initial success. CONCLUSIONS: FemoStop compression for iatrogenic pseudoaneurysm is feasible, and as safe and effective as freehand ultrasound guided compression repair. It is more comfortable for the patient and operator, and probably more economical than freehand compression.

Adult↗
PubMed1998

Discrepancy of clinical and angiographic results in the follow-up of percutaneous transluminal renal angioplasty (PTRA).

BACKGROUND: To investigate the value of recurrent hypertension as indicator for renal artery patency after PTRA clinical and angiographic follow-up results were analysed. PATIENTS AND METHODS: results of 66 follow-up angiographies and blood pressure measurements were available in 55 patients after technically and clinically successful PTRA. Out of 43 patients with atherosclerosis, in 33 was recurrent hypertension present, and in ten patients none. Of 12 angiographies in patients with fibromuscular dysplasia nine were done because of recurrent hypertension. RESULTS: In atherosclerosis, 21 (64%) out of 33 patients with recurrent hypertension showed a re-stenosis by > 70%, and 12 (36%) none. Out of the ten follow-up angiographies performed in patients with no recurrence, two showed an unexpected stenosis. In fibromuscular dysplasia, stenoses were present in seven cases (77%). Four of them were at the site of PTRA (44%), while three were at a new site (33%). The follow-up angiographies in three patients with no recurrence showed patent arteries. Out of 11 further angiographies carried out because of hypertension after repeated PTRA, only three revealed re-stenosis. CONCLUSIONS: In only about 35% of all patients with recurrent hypertension re-stenosis was shown in angiography but in 15% of asymptomatic patients. Recurrence of hypertension after PTRA and renal artery stenosis is not well correlated. Thus, follow-up should be performed not only clinically but also by direct examination of renal artery patency such as by ultrasound.

Adult↗
PubMed1998

[Ulcus cruris--vascular etiology and surgical treatment options].

Leg ulcers comprise a problem with various contributing factors requiring selective therapy adapted to the underlying cause. The majority can be classified as arterial (approx. 20%) or venous (approx. 80%) ulcers. Arterial ulcers as well as most mixed (arterial-venous) ulcers can be treated by arterial reconstruction and subsequent skin grafting, with additional ligation of perforator veins or (segmental) stripping of the saphenous vein. Leg ulcers due to chronic insufficiency of the deep venous system are most often the result of previous deep venous thrombosis followed by recanalization and development of a postthrombotic syndrome. Compression regimens remain standard therapy with emphasis on preventing ulcer formation. Ulcer healing can be achieved by compression therapy although recurrence rates are high. Surgery is not the treatment of first choice for leg ulcers, however, in selected cases surgical therapy is indicated. To prevent recurrence, continued consistent compression, keeping the patient well-informed and offering supportive guidance are imperative.

Diagnosis, Differential↗
PubMed1997

Human connective tissue growth factor is expressed in advanced atherosclerotic lesions.

BACKGROUND: Atherosclerosis affects certain but not all vascular beds of the human circulation. Its molecular mechanisms are only partially understood. Human connective tissue growth factor (hCTGF) is a novel cysteine-rich, secreted polypeptide. hCTGF is implicated in connective tissue formation, which may play an important role in atherosclerosis. METHODS AND RESULTS: By using a differential cloning technique, we isolated a cDNA clone from a human aorta cDNA library, which is identical to hCTGF. Northern analysis shows that hCTGF mRNA was expressed at 50- to 100-fold higher levels in atherosclerotic blood vessels compared with normal arteries. In vascular smooth muscle cells, high-level expression of hCTGF mRNA was induced by transforming growth factor-beta 1. Using in situ hybridization and immunohistochemistry, we found that all advanced atherosclerotic lesions of human carotid arteries (eight patients; mean age, 69; age range, 57 to 85 years) and femoral arteries (two patients; mean age, 71.5 years) that we tested expressed high levels of both hCTGF mRNA and protein. hCTGF expression was localized mainly to smooth muscle cells in the plaque lesions that are negative for proliferating cell nuclear antigen staining. In addition, some CD-31-positive endothelial cells of plaque vessels expressed high levels of hCTGF mRNA and protein. hCTGF-positive cells were found predominantly in areas with extracellular matrix accumulation and fibrosis. In contrast, in normal arteries, we were unable to detect either hCTGF mRNA or immunoreactive hCTGF protein. CONCLUSIONS: In the present study, we have shown for the first time that both hCTGF mRNA and protein are expressed in human arteries in vivo and that hCTGF may represent a novel factor expressed at high levels specifically in advanced lesions and may play a role in the development and progression of atherosclerosis.

Adult↗
PubMed1997

Unusual pseudoaneurysms after catheterization: successful treatment by ultrasound-guided compression.

Postcatheterization pseudoaneurysms occur mostly in the femoral artery. Two patients (both women, aged 67 and 59 years) undergoing percutaneous transluminal angioplasty (PTA) at our institution presented pseudoaneurysms in unusual locations, one in the brachial and one in the popliteal artery. Because of good experiences with ultrasound-guided compression repair (UGCR) in the femoral artery, we also successfully performed this noninvasive treatment on the two patients. Follow-up at 28 and 12 months, respectively, after the procedure, showed no instances of recurrence. As with the excellent results of UGCR in the femoral artery, we believe that this new modality is also the treatment of choice in iatrogenic pseudoaneurysms of the arm and popliteal arteries.

Aged↗